Truist Financial
MRVI icon

Truist Financial’s Maravai LifeSciences MRVI Stock Holding History

Truist Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,673
Closed -$119K – 2643
2024
Q2 		$119K Sell
16,673
-516
-3% -$4.46K ﹤0.01% 2572
2024
Q1 		$149K Buy
17,189
+2,121
+14% +$14.3K ﹤0.01% 2528
2023
Q4 		$98.7K Sell
15,068
-4,379
-23% -$28.3K ﹤0.01% 2567
2023
Q3 		$194K Sell
19,447
-4,916
-20% -$54K ﹤0.01% 2447
2023
Q2 		$303K Buy
24,363
+1,050
+5% +$14.2K ﹤0.01% 2243
2023
Q1 		$327K Buy
+23,313
New +$335K ﹤0.01% 2224
2021
Q4 		– Sell
-5,853
Closed -$287K – 2811
2021
Q3 		$287K Sell
5,853
-814
-12% -$39.7K ﹤0.01% 2378
2021
Q2 		$278K Buy
+6,667
New +$258K ﹤0.01% 2413

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Truist Financial's MRVI Position: Q3 2024 in Review

Truist Financial sold out of Maravai LifeSciences (MRVI) in Q3 2024, closing a stake of 16,673 shares — an estimated $119K sold.

Truist Financial first reported a position in MRVI in Q2 2021 and held it in 8 quarters. The position peaked at $327K in Q1 2023. 217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

  • Truist Financial reported no remaining Maravai LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Truist Financial sold 16,673 Maravai LifeSciences shares in Q3 2024, an estimated $119K.
  • Truist Financial first reported a position in Maravai LifeSciences in Q2 2021 and held it in 8 quarters.
  • Truist Financial's Maravai LifeSciences position peaked at $327K in Q1 2023.
  • 217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on Truist Financial's 13F filing for Q3 2024, filed 13 Nov 2024.